NCT04996875Phase 2Recruiting

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Study sponsor: Cogent Biosciences, Inc. · COGT

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-09-19Actual
Enrollment · participants140Estimated
Source updated2026-09-15Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Sep 2025. After: 19 Sep 2025.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview